Literature for inhibitor I02.013: tissue factor pathway inhibitor-2 inhibitor unit 1

(Topics flags: S Structure. To select only the references relevant to a single topic, click the link above. See explanation.)

2020
1. Vadivel,K., Zaiss,A.K., Kumar,Y., Fabian,F.M., Ismail,A.E.A., Arbing,M.A., Buchholz,W.G., Velander,W.H. and Bajaj,S.P.
   Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1
   J Clin Med9, PubMed  Europe PubMed DOI
2016
2. Vadivel,K., Kumar,Y., Ogueli,G.I., Ponnuraj,S.M., Wongkongkathep,P., Loo,J.A., Bajaj,M.S. and Bajaj,S.P.
   S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin
   J Thromb Haemost14, 2509-2523. PubMed  Europe PubMed DOI
2014
3. Kumar,Y., Vadivel,K., Schmidt,A.E., Ogueli,G.I., Ponnuraj,S.M., Rannulu,N., Loo,J.A., Bajaj,M.S. and Bajaj,S.P.
   Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain
   Biochemistry53, 505-517. PubMed  Europe PubMed DOI
2011
4. Bajaj,M.S., Ogueli,G.I., Kumar,Y., Vadivel,K., Lawson,G., Shanker,S., Schmidt,A.E. and Bajaj,S.P.
   Engineering Kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant
   J Biol Chem286, 4329-4340. PubMed  Europe PubMed DOI
2005
5. [YEAR:2-6-2005]Schmidt,A.E., Chand,H.S., Cascio,D., Kisiel,W. and Bajaj,S.P.
   Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition
   J Biol Chem280, 27832-27838. PubMed  Europe PubMed DOI  S
2004
6. [YEAR:16-2-2004]Chand,H.S., Schmidt,A.E., Bajaj,S.P. and Kisiel,W.
   Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2
   J Biol Chem279, 17500-17507. PubMed  Europe PubMed DOI
7. [YEAR:26-11-2004]Kong,D., Ma,D., Bai,H., Guo,H., Cai,X., Mo,W., Tang,Q. and Song,H.
   Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2
   Biochem Biophys Res Commun324, 1179-1185. PubMed  Europe PubMed DOI
1999
8. [YEAR:1-5-1999]Kamei,S., Petersen,L.C., Sprecher,C.A., Foster,D.C. and Kisiel,W.
   Inhibitory properties of human recombinant Arg24 - >Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2)
   Thromb Res94, 147-152. PubMed  Europe PubMed DOI
1998
9. Johnson,K., Zaror,I., Bauer,D., Choi,Y., Creasey,A. and Innis,M.
   Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor
   Thromb Haemost80, 585-587. PubMed  Europe PubMed